S3E10 - Hepatitis Management for Australian Clinical Exams

<p><strong>Welcome to Season 3 of AMC Clinical Deep Dive! </strong></p><p><br></p><p>This episode deconstructs the ASHM guidelines for Hepatitis A, B, and C. Learn key diagnostic rules: why &quot;no healthy carrier&quot; exists in Hepatitis B, and why Hepatitis C antibody tests should never be repeated once positive (use HCV PCR instead). We cover high-yield protocols: Hepatitis A contact tracing across a 50-day window, 6-monthly hepatocellular carcinoma screening for chronic Hep B, and Direct-Acting Antiviral (DAA) cure pathways for Hep C. Differentiate acute versus chronic management, Australian vaccination rules, and essential post-exposure prophylaxis to ace your OSCE consult!</p><p><br></p><p>#AMCClinicalExam #ViralHepatitis #OSCE #HepatitisB #HepatitisC #HepAContactTracing #IMGAustralia #HCCScreening #HCVPCR #HBsAgManagement</p><p><br></p><p><strong>Pro Tip:</strong> In your OSCE, examiners closely monitor your understanding of long-term safety and serology interpretation! Remember that <strong>no &quot;healthy carrier&quot; exists for Hepatitis B</strong>; all HBsAg-positive patients require ongoing monitoring and 6-monthly HCC screening if indicated. For Hepatitis C, never order a repeat antibody test if previously positive—always use <strong>HCV PCR to detect active infection or re-infection</strong>. Finally, emphasise that <strong>DAA therapy can cure Hep C</strong>, but past clearance provides zero immunity against future re-infection!</p><p><br></p><p>🎧 <a href="https://apwix.com/100509">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a> Episodes in <a href="https://apwix.com/100509">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠<strong>Season 1</strong>⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠</a> (<em>150 clinical scenarios</em>) have been indexed by <strong>topic</strong>, <strong>patient group</strong>, <strong>discipline</strong>, <strong>setting</strong>, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.</p>